MX2010006166A - Compuestos amida como refuerzos de antivirales. - Google Patents

Compuestos amida como refuerzos de antivirales.

Info

Publication number
MX2010006166A
MX2010006166A MX2010006166A MX2010006166A MX2010006166A MX 2010006166 A MX2010006166 A MX 2010006166A MX 2010006166 A MX2010006166 A MX 2010006166A MX 2010006166 A MX2010006166 A MX 2010006166A MX 2010006166 A MX2010006166 A MX 2010006166A
Authority
MX
Mexico
Prior art keywords
boosters
compounds
antivirals
amide compounds
certain drugs
Prior art date
Application number
MX2010006166A
Other languages
English (en)
Inventor
Klooster Gerben Albert Eleutherius Van T
Tim Hugo Maria Jonckers
Wim Bert Griet Schepens
Judith Eva Baumeister
Geerwin Yvonne Paul Hache
Beate Sabine Hallenberger
Jennifer Chiyomi Sasaki
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39386111&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010006166(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of MX2010006166A publication Critical patent/MX2010006166A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a compuestos que tienen propiedades inhibidoras de CYP45O y por lo tanto son útiles como refuerzos de determinados fármacos, es decir, son capaces de aumentar por lo menos una de las variables farmacocinéticas de determinados fármacos cuando se co-administran; la invención proporciona además el uso de dichos compuestos como mejoradores de la biodisponibilidad de determinados fármacos; además se proporcionan métodos para la preparación de los compuestos de la invención y composiciones farmacéuticas.
MX2010006166A 2007-12-06 2008-12-05 Compuestos amida como refuerzos de antivirales. MX2010006166A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122468 2007-12-06
PCT/EP2008/066847 WO2009071650A2 (en) 2007-12-06 2008-12-05 Amide compounds as boosters of antivirals

Publications (1)

Publication Number Publication Date
MX2010006166A true MX2010006166A (es) 2010-10-05

Family

ID=39386111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006166A MX2010006166A (es) 2007-12-06 2008-12-05 Compuestos amida como refuerzos de antivirales.

Country Status (24)

Country Link
US (1) US8350048B2 (es)
EP (1) EP2235008B1 (es)
JP (1) JP5509092B2 (es)
KR (1) KR101624675B1 (es)
CN (1) CN101878210B (es)
AP (1) AP2804A (es)
AR (1) AR069595A1 (es)
AU (1) AU2008333165B2 (es)
BR (1) BRPI0821021A2 (es)
CA (1) CA2706155C (es)
CL (1) CL2008003639A1 (es)
EA (1) EA019616B1 (es)
HK (1) HK1149553A1 (es)
IL (1) IL205489A (es)
MX (1) MX2010006166A (es)
MY (1) MY151005A (es)
NZ (1) NZ585652A (es)
PA (1) PA8806801A1 (es)
PE (1) PE20091263A1 (es)
TW (1) TWI438202B (es)
UA (1) UA103013C2 (es)
UY (1) UY31513A1 (es)
WO (1) WO2009071650A2 (es)
ZA (1) ZA201004025B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA026673B1 (ru) * 2008-10-07 2017-05-31 Янссен Сайенсиз Айрлэнд Юси Амидные соединения в качестве усилителей противовирусных препаратов
US20120172368A1 (en) * 2009-09-03 2012-07-05 Koen Vandyck Bis-Benzimidazole Derivatives
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
CA2833006A1 (en) * 2011-04-22 2012-10-26 Merck Sharp & Dohme Corp. Taste-masked formulations of raltegravir
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
CN105985356B (zh) * 2015-02-05 2018-06-22 四川大学 咪唑[2,1-b]噻唑衍生物及其制备方法和用途
CA3007025A1 (en) 2015-12-22 2017-06-29 Kancera Ab Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
AR114136A1 (es) 2017-10-10 2020-07-29 Hoffmann La Roche Compuestos heterocíclicos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
KR101327772B1 (ko) * 2002-08-02 2013-11-11 얀센 알 앤드 디 아일랜드 광범위 2-아미노-벤조티아졸 설폰아미드 ｈｉｖ 프로테아제 저해제
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US8048871B2 (en) 2006-08-18 2011-11-01 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome P450

Also Published As

Publication number Publication date
PE20091263A1 (es) 2009-08-14
ZA201004025B (en) 2011-12-28
BRPI0821021A2 (pt) 2015-06-16
KR20100092489A (ko) 2010-08-20
TWI438202B (zh) 2014-05-21
AR069595A1 (es) 2010-02-03
MY151005A (en) 2014-03-31
AU2008333165A1 (en) 2009-06-11
KR101624675B1 (ko) 2016-05-27
CA2706155A1 (en) 2009-06-11
US20100305073A1 (en) 2010-12-02
CL2008003639A1 (es) 2010-01-15
TW200938540A (en) 2009-09-16
CA2706155C (en) 2016-07-19
PA8806801A1 (es) 2009-07-23
AP2010005285A0 (en) 2010-06-30
AP2804A (en) 2013-11-30
UA103013C2 (uk) 2013-09-10
CN101878210A (zh) 2010-11-03
NZ585652A (en) 2011-10-28
EP2235008A2 (en) 2010-10-06
EA201070691A1 (ru) 2010-10-29
HK1149553A1 (en) 2011-10-07
JP2011506291A (ja) 2011-03-03
UY31513A1 (es) 2009-07-17
IL205489A (en) 2016-09-29
IL205489A0 (en) 2010-12-30
JP5509092B2 (ja) 2014-06-04
EA019616B1 (ru) 2014-05-30
US8350048B2 (en) 2013-01-08
WO2009071650A2 (en) 2009-06-11
CN101878210B (zh) 2013-07-17
WO2009071650A3 (en) 2009-09-11
EP2235008B1 (en) 2016-03-16
AU2008333165B2 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
MX2010006166A (es) Compuestos amida como refuerzos de antivirales.
MX2013001970A (es) Compuestos de pirrolopirimidina y usos de los mismos.
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MX2010009646A (es) Agentes terapeuticos antivirales.
MY148634A (en) Pyridazinone derivatives
MY151246A (en) Benzofuranyl derivatives
IN2012DN01233A (es)
MX2012002366A (es) Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
MX2011005934A (es) Compuestos organicos.
MX2010003001A (es) Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
UA103198C2 (en) Squaramide derivatives as cxcr2 antagonists
TW200942535A (en) Novel compounds as cannabinoid receptor ligands
MX2012004780A (es) Inhibidores de akt.
TW200738653A (en) Anthranilamide/2-amino-heteroarene carboxamide derivatives
IN2012DN02139A (es)
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
JO2849B1 (en) Dopamine 2 receptor antagonists are rapidly hydrolyzed
IN2012DN02793A (es)
MX2012015100A (es) Compuestos y composiciones de heteroarilo como inhibidores de cinasa de proteina.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
UA103996C2 (en) Ivabradine hydrobromide

Legal Events

Date Code Title Description
FG Grant or registration